These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31934283)

  • 1. MicroRNA-940 inhibits epithelial-mesenchymal transition of glioma cells via targeting ZEB2.
    Xu R; Zhou F; Yu T; Xu G; Zhang J; Wang Y; Zhao L; Liu N
    Am J Transl Res; 2019; 11(12):7351-7363. PubMed ID: 31934283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1.
    Luo H; Xu R; Chen B; Dong S; Zhou F; Yu T; Xu G; Zhang J; Wang Y; You Y
    Am J Transl Res; 2019; 11(8):4851-4865. PubMed ID: 31497204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.
    Lin X; Yang Z; Zhang P; Liu Y; Shao G
    Oncol Lett; 2016 Jul; 12(1):301-306. PubMed ID: 27347142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-212-3p inhibits paclitaxel resistance through regulating epithelial-mesenchymal transition, migration and invasion by targeting ZEB2 in human hepatocellular carcinoma.
    Yang J; Cui R; Liu Y
    Oncol Lett; 2020 Oct; 20(4):23. PubMed ID: 32774496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
    Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z
    Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-623 Inhibits Epithelial-Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44.
    Cui D; Wang K; Liu Y; Gao J; Cui J
    Onco Targets Ther; 2020; 13():9291-9303. PubMed ID: 33061418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2.
    Fei D; Zhao K; Yuan H; Xing J; Zhao D
    Am J Cancer Res; 2016; 6(12):2859-2868. PubMed ID: 28042505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
    Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
    Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
    Zhang X; Wei C; Li J; Liu J; Qu J
    Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-378 acts as a prognosis marker and inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting IRG1.
    Shi HZ; Wang D; Sun XN; Sheng L
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3837-3846. PubMed ID: 29949160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.